CSG Charts Aggressive Expansion on Two Fronts Even as Share Price Plunges 53%

Czechoslovak Group pursues KNDS stake and 20% ammo capacity hike, but shares plunge 53% amid short-seller doubts and market skepticism.

The Czechoslovak Group (CSG) is pursuing a dual-pronged growth push — a potential foothold in a European tank-making giant and a sharp increase in internal munitions output — yet the Amsterdam-listed stock continues to bleed value under the weight of a short-seller assault and persistent market scepticism.

Owner Michal Strnad has opened exploratory talks in Berlin and Paris about acquiring a stake in KNDS, the Franco-German manufacturer of Leopard tanks and other land systems. A deal would vault CSG into the ranks of Europe's second-largest defence contractor, adding a marquee name in armoured vehicles to a portfolio that already spans aerospace, ammunition, automotive and railway technology and employs upwards of 14,000 people worldwide. No concrete outcome from those talks has been disclosed, and the financing question — the group's market capitalisation stands at roughly €16 billion — looms over any transaction.

On the production side, management reaffirmed its 2026 revenue target of €7.4 billion to €7.6 billion, representing double-digit annual growth. The forecast is underpinned by a record backlog of more than €11 billion at the start of the year, almost all from NATO states that have contributed over 90% of revenue historically. To meet demand, CSG is expanding in-house ammunition capacity by about 20% this year, anchored by a new production line in Slovakia that will add 70,000 large-calibre rounds annually. The company's medium-term goal is to reach a total capacity of 1.1 million shells, using a vertically integrated network spanning Spain, Serbia, Greece and India to cut reliance on external suppliers and recycled stocks.

None of these ambitions, however, has been able to arrest the slide in CSG's shares. The stock closed at €15.98 on Wednesday, tumbling almost 53% from the January record of €33.81 and shedding more than a quarter of its value in the past 30 days alone. Annualised volatility has surged past 77%, underlining the market's unease with the pace of the group's expansion. A report from an activist short seller in May, which challenged CSG's production figures and specific framework agreements, triggered the latest leg of the sell-off. The company has rejected the allegations, defended the integrity of its listing prospectuses and said it is weighing legal action.

Earlier catalysts — including the unveiling of a new armoured vehicle project and a billion-euro EU contract — failed to provide lasting support. Investors remain wary, and the strategic rationale for moves such as the KNDS approach has not yet been translated into a higher valuation. By contrast, the forward price-to-earnings ratio of 15 is well below the European defence sector average of 25, suggesting the stock is priced for deep discount.

The next significant test comes on May 20, when CSG publishes its first-quarter financial results. The report will offer verified data on actual production throughput and cash generation, and a strong print could help validate the company's internal milestones for the 2026 production ramp. Until then, the gap between operational momentum and market perception remains wide.